Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026
Go back to Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 238.98 -1.09 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $240.07 | 52 Week High | $160.00 | |||
| Open | $238.38 | 52 Week Low | $95.80 | |||
| Day High | $239.55 | P/E | 44.42 | |||
| Day Low | $236.00 | EPS | $5.38 | |||
| Volume | 13,880 | |||||
